"Gene Therapy To Fix Failing Hearts Works In Pigs And Will Be Tried In Humans In 2018" - Brian Wang

Mount Sinai Awarded $2 Million to Launch International Clinical Trial on Spontaneous Coronary Artery Dissection

Monoclonal Antibody Targeting Interleukin-6 Achieves Sustained Reductions in Inflammation Biomarkers Through Six Months

The Ross Procedure Is Associated With Excellent Outcomes, Durability, and Efficacy in a Wide Range of Adults With Aortic Valve Disease

Healthy Sleep and Regular Exercise Can Mitigate the Genetic Cardiovascular Risk of Mutant White Blood Cells

Mount Sinai Researchers Develop Machine Learning Model to Predict How CPAP Affects Cardiovascular Disease Risk in Patients With Obstructive Sleep Apnea

Mount Sinai Launches Adams Valve Institute, Specializing in Complex Valve Surgery and Valvular Heart Disease

Nearly 30 Percent of Patients With Resistant Hypertension Have a Hormone Disorder Caused by High Cortisol

Mount Sinai’s Roxana Mehran, MD, Named President of the American College of Cardiology

Microaxial Flow Pump Does Not Improve Outcomes for High-Risk Heart Attack Patients Without Cardiogenic Shock

Colder Weather Linked to 40,000 Heart-Related Deaths Yearly in the United States, Study Finds

AI-Powered ECG Could Help Guide Lifelong Heart Monitoring for Patients With Repaired Tetralogy of Fallot